抗真菌耐药性,组合和管道:!
Kayla R Stover1, Brandon K Hawkins2, J Myles Keck3
1Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, MS, USA.
Drugs in context
|November 29, 2023
概括
侵袭性真菌感染是越来越令人担忧的,因为耐药性越来越高. 像fosmanogepix,ibrexafungerp,olorofim和rezafungin这样的新型抗真菌疗法在解决这些挑战方面表现有前途.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 菌类学 菌类学是指菌类学.
背景情况:
- 侵入性真菌感染 (IFI) 显著增加医疗保健成本,发病率和死亡率,特别是在住院患者中.
- 从历史上看, *Candida* 种类占医院血流感染的15%左右,但随着耐药菌株的流行率的增加,流行病学发生了转变.
- 抗真菌耐药性的上升需要开发新的治疗药物.
研究的目的:
- 审查侵入性真菌感染的流行病学,重点关注抗真菌耐药性的日益流行.
- 讨论当前抗真菌疗法的局限性,包括副作用和多药耐药病原体的出现.
- 突出新兴的抗真菌药物,这些药物可以解决管理国际金融机构的未满足需求.
主要方法:
- 关于入侵性真菌感染和抗真菌耐药性的最近研究的文献综述.
- 分析目前抗真菌药物开发的现状.
- 讨论新兴的抗真菌剂及其潜在的临床应用.
主要成果:
- 耐药的 *Candida* 种类的流行率有所增加,推动了对新的抗真菌治疗的需求.
- 现有的抗真菌疗法可能会产生剂量限制的副作用,而多抗药性病原体仍然是一个临床挑战.
- 像fosmanogepix,ibrexafungerp,olorofim和rezafungin这样的新药在活性范围和安全性方面提供了潜在的改进.
结论:
- 新型抗真菌剂对于对抗侵袭性真菌感染和抗真菌耐药性的日益增长的威胁至关重要.
- 佛斯曼诺格皮克斯,ibrexafungerp,olorofim和rezafungin代表了对抗真菌武器库的有希望的补充.
- 需要继续进行研究和开发,以解决复杂的真菌感染和耐药性模式.
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K


